Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico

5 trials 4 recruiting Academic / non-commercial

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

0 Completed trials

1 Countries active

12 Unique IMPs

N/A Results reported

Phase II

Phase IV

Phase II: 4 Phase IV: 1

Top IMPs

(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE 1 ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 3350 1 ATEZOLIZUMAB 1 BEVACIZUMAB 1 BLEOMYCIN SULFATE 1 CARBOPLATIN 1 GLUTATHIONE (REDUCED), SODIUM SALT 1 HUMAN PLASMA PROTEINS WITH NOT LESS THAN 96% ALBUMIN 1 METYRAPONE 1 SIMETICONE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 4000 1 VANCOMYCIN 1 VANCOMYCIN HYDROCHLORIDE 1

All trials

5 total

Electrochemotherapy with Carboplatinum plus Bleomycin versus Bleomycin alone in vulvar cancer: the ElechtraPlatinum Study. A Randomized Cont… Pending

2024-518370-14-00 Phase II 1 country BLEOMYCIN SULFATE; CARBOPLATIN
Fecal Microbiota Transplantation to RESCUE patients with unresectable Hcc progressors to first line therapy with AtezolizUmaB and Bevacizuma… Recruiting

2023-510504-45-00 Phase II 1 country ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SUL…
Safety and efficacy of a human albumin solution with restored structural profile in patients with decompensated cirrhosis Recruiting

2024-515484-54-00 Phase II 1 country GLUTATHIONE (REDUCED), SODIUM SALT; HUMAN PLASMA PROTEINS WITH NOT LESS THAN 96%…
Role of [68Ga]Ga-FAPI PET/CT in oncological patients with doubtful or inconclusive findings at [18F]F-FDG PET/CT Recruiting

2024-518765-96-00 Phase II 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
Effect of metyrapone on cardiovascular risk factors in patients with adrenal incidentalomas and subclinical/mild Cushing's syndrome Recruiting

2024-518932-34-00 Phase IV 1 country METYRAPONE

Showing 1–5 of 5 trials

← All sponsors A–Z